The Global Complement Inhibitors Market Offers Lucrative Growth Opportunities Owing to Rising Chronic Inflammatory & Autoimmune Diseases
Complement inhibitors are monoclonal antibodies used to treat chronic inflammatory and autoimmune diseases by blocking the complement system, a part of the innate immune system. They help reduce inflammation and prevent tissue damage. The rising prevalence of conditions like paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and myasthenia gravis is fueling...
0 Comentários 0 Compartilhamentos 925 Visualizações 0 Anterior